LXRX Q1 2018 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M+37.8% YoY

Gross Profit

$25M97.9% margin

Operating Income

-$38M-150.6% margin

Net Income

-$42M-166.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-23.7%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$47M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$387M

Total Liabilities

$361M

Stockholders' Equity

$26M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$18M	+37.8%
Gross Profit	$25M	$18M	+36.6%
Operating Income	-$38M	-$42M	+10.6%
Net Income	-$42M	-$35M	-20.6%